Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 119
Selected: 0
NCT IDTitle
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT06886282Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease
NCT04416672Validation of the Italian Version of the PRO-CTCAE
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
NCT03503786Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
NCT00540800BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT03874026Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
NCT00345059The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT06905262Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT01649674Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT05806151Prediction of True Oligo-metastatic Disease.
NCT00401492MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
NCT06866093The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.
NCT05255471MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
NCT00996983Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer
NCT01628211Second Look Laparoscopy in Colorectal Cancer
NCT07577206Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
NCT06341764Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma
NCT06894823Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT04139772Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
NCT06509126Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
NCT00434031CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
NCT04397601Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
NCT04091204Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study
NCT01706120Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
NCT03975114A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5)
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT07269249Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
NCT01074684Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT00526396STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
NCT00331097ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
NCT02619435Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT06893861Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT00401427HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
NCT03473379Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy
NCT03380858REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT03203005IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT01651026Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT05733793Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
NCT06270602The ONCOCAMP Study
NCT02069067Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated